CareMax Future Growth

Future criteria checks 1/6

CareMax is forecast to grow earnings and revenue by 73.7% and 14.4% per annum respectively while EPS is expected to grow by 80.2% per annum.

Key information

73.7%

Earnings growth rate

80.2%

EPS growth rate

Healthcare earnings growth17.2%
Revenue growth rate14.4%
Future return on equityn/a
Analyst coverage

Low

Last updated05 Jun 2024

Recent future growth updates

Recent updates

CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Jun 20
CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

May 13
Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

Mar 11
Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

CareMax: Numbers Are Strong, Compelling Value On Offer

Sep 16

CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M

Aug 09

CareMax: Steward Health Care Acquisition Highlights Growth Ambitions

Jul 02

CareMax: Network Of Comprehensive Care Centers Serving Medicare Beneficiaries

Oct 18

Earnings and Revenue Growth Forecasts

NasdaqGS:CMAX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,128-626171
12/31/20251,071-103-51-433
12/31/2024892-1442111
3/31/2024810-645-61-49N/A
12/31/2023751-683-62-47N/A
9/30/2023764-207-101-91N/A
6/30/2023719-126-94-84N/A
3/31/2023667-103-86-78N/A
12/31/2022631-38-76-68N/A
9/30/2022585-52-61-55N/A
6/30/2022532-44-54-48N/A
3/31/2022405-25-43-39N/A
12/31/2021296-7-28-24N/A
9/30/2021206-2-13-9N/A
6/30/202112512-4-2N/A
3/31/2021106657N/A
12/31/2020103835N/A
9/30/2020101758N/A
12/31/201991667N/A
12/31/201872301N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CMAX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CMAX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CMAX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CMAX's revenue (14.4% per year) is forecast to grow faster than the US market (8.7% per year).

High Growth Revenue: CMAX's revenue (14.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CMAX's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.